Innovative drugs treating hepatitis to appear in Kazakhstan - News | BNews

Innovative drugs treating hepatitis to appear in Kazakhstan

02 February, 10:30 282
Innovative drugs treating hepatitis to appear in Kazakhstan

In the near future, innovative drugs to treat virus hepatitis will be appeared in Kazakhstan.

The most advanced treatment of virus hepatitis with the use of innovative drugs as Sofosbuvir and Daclatasvir will be available for Kazakhstani patients owing to the agreements signed today between the Ministry of Healthcare of Kazakhstan and the UN Development Program. The signing ceremony was attended Resident Representative of the UNDP for Kazakhstan Norimasa Shimomura and Health Minister of Kazakhstan Yelzhan Birtanov, “SK-Pharmacy” reports.

Within the Address of the head of state, the Ministry pays a particular attention to supply the population with drugs for treating socially significant diseases, including hepatitis C virus.

"From 2018, the Ministry and the Single Drug Distributor SK-Pharmacy, with the support of the UNDP, will begin delivering the most advanced antiviral drugs for the treatment of viral hepatitis. The drugs will be provided to Kazakhstani patients on a free basis," says the report.

According to the Minister of Healthcare of the Republic of Kazakhstan, Yelzhan Birtanov, the possibility to purchase drugs with the support of the United Nations Development Program opens access to the most modern and, to date, the most effective treatment for viral hepatitis, which in most cases allows to finally get rid of the presence of the virus in the body. Within the framework of the agreement, it is planned to purchase drugs worth about 1.5 billion tenge.

"The drug is included in the list of essential medicines by the WHO. With the support of the United Nations Development Program, we will be able to maximally embrace Kazakhstani patients with modern treatment of viral hepatitis," Yelzhan Birtanov said during the signing ceremony.

"The UNDP mandate is aimed at increasing human potential throughout life, and we are convinced that a full and active life cannot be achieved without widespread access to modern medical services and drugs, and we hope that this initiative will not only help reduce the incidence of hepatitis C, but will also improve the quality of life of thousands of Kazakhstanis and their families," the UNDP Resident Representative for Kazakhstan, Norimasa Shimomura, said during the ceremony.

`